๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Adult T-Cell Leukemia/Lymphoma (ATLL)

VHAG in Treating R/R T-ALL/LBL NCT06742463Phase 21 site๐Ÿ“ Hangzhou First Affiliated Hospital of Zhejiang University ยท Tests: Venetoclax, homoharringtonine, Cytarabine (Ara-C), G-CSF Nanobody-Based Anti-CD5 CAR-T for Relapsed/Refractory T-ALL/NHL NCT06874946Phase 1, Phase 21 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: CD5-targeted CAR-T cells Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations NCT07012447Phase 21 site๐Ÿ“ Suzhou yuejun Liu ยท Tests: Venetoclax, Azacitidine, Cytarabine A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) NCT06207123Phase 1, Phase 22 sites๐Ÿ“ Chicago๐Ÿ“ Rochester University of Chicago ยท Tests: LP-118, Ponatinib, Vincristine, Dexamethasone, Methotrexate Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma NCT07356245Phase 21 site๐Ÿ“ Columbus Jonathan Brammer ยท Tests: Ruxolitinib, Positron emission tomography-computed tomography, Bone Marrow Biopsy, Biopsy Procedure, Biospecimen Collecโ€ฆ A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy) NCT06561074Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Decitabine, Venetoclax, Calaspargase pegol-mknl CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia NCT05043571Phase 11 site๐Ÿ“ Singapore National University Hospital, Singapore ยท Tests: CAR T-cell therapy A Study of CTD402 in T-ALL/LBL Patients NCT07070219Phase 1, Phase 29 sites๐Ÿ“ Palo Alto๐Ÿ“ Denver๐Ÿ“ Chicago Imviva Bio ยท Tests: CTD402 CAR T Cell Injection SupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies NCT07153068Phase 1, Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: supCD7 CART cells A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma NCT07075328Phase 1, Phase 25 sites๐Ÿ“ Fukuoka๐Ÿ“ Sapporo๐Ÿ“ Kagoshima Otsuka Medical Devices Co., Ltd. Japan ยท Tests: Drug:5-ALA, Device:Photodynamic system To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT NCT07280494Phase 11 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: CAR-T Therapy Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma NCT07388563Phase 11 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: azacitidine, abatacept The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors NCT06911710Phase 1, Phase 21 site๐Ÿ“ Tianjin Tianjin Medical University General Hospital ยท Tests: CAR-T Cells infusion๏ผˆCAR2219,CAR2019, CAR19 etc๏ผ‰ Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL) NCT04301076Phase 119 sites๐Ÿ“ Atlanta๐Ÿ“ Atlanta๐Ÿ“ City of Saint Peters National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography, Cyclophosphamide, Doxorubicin Hydrochloride Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment NCT01087333n/a1 site๐Ÿ“ Bethesda National Cancer Institute (NCI) Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL NCT05626400NA1 site๐Ÿ“ Beijingcun Hebei Senlang Biotechnology Inc., Ltd. ยท Tests: Senl-T7 Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL NCT05289687Phase 21 site๐Ÿ“ Chicago Eastern Cooperative Oncology Group ยท Tests: Daratumumab / Hyaluronidase Injection, Daratumumab / Hyaluronidase Injection, Daratumumab / Hyaluronidase Injection, Daโ€ฆ Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells NCT06420076Phase 1, Phase 21 site๐Ÿ“ Beijing Essen Biotech ยท Tests: CD5/CD7 CAR-T Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab NCT04014374n/a1 site๐Ÿ“ Milwaukee Kyowa Kirin, Inc. Haplo-cord HCT vs. Haplo-HCT for T-ALL Patients NCT06381817Phase 31 site๐Ÿ“ Suzhou The First Affiliated Hospital of Soochow University ยท Tests: Haplo-cord HCT, Haplo-HCT Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia NCT06648889Phase 215 sites๐Ÿ“ Augsburg๐Ÿ“ Berlin๐Ÿ“ Bremen Goethe University ยท Tests: Isatuximab, Isatuximab Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies NCT06909474Phase 11 site๐Ÿ“ Wuhan Chongqing Precision Biotech Co., Ltd ยท Tests: Anti-CD5 CAR NK cells uCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies NCT07109518Phase 11 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: uCD7 CART Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL NCT06633354EARLY Phase 11 site๐Ÿ“ Hangzhou Zhejiang University ยท Tests: CD5 CAR T-cells Novel Therapeutic Approach for Human T-cell Malignancies NCT06600568n/a2 sites๐Ÿ“ Naples๐Ÿ“ Padova Istituto Oncologico Veneto IRCCS ยท Tests: Translation analysis Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients NCT07159620Phase 21 site๐Ÿ“ Suzhou The First Affiliated Hospital of Soochow University ยท Tests: VEN (Venetoclax), Azacitidine (AZA), Chidamide, vindesine, Dexamethasone Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL NCT07203352Phase 31 site๐Ÿ“ Guangzhou Nanfang Hospital, Southern Medical University ยท Tests: targeted drug Safety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LL NCT05679895Phase 12 sites๐Ÿ“ Barcelona๐Ÿ“ Barcelona OneChain Immunotherapeutics ยท Tests: CD1a-CAR T CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML) NCT04318678Phase 12 sites๐Ÿ“ Memphis๐Ÿ“ Memphis St. Jude Children's Research Hospital ยท Tests: CD123-CAR T, Cyclophosphamide, Fludarabine, Mesna, Rituximab Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma NCT05996185Phase 22 sites๐Ÿ“ New Haven๐Ÿ“ New York Yale University ยท Tests: Mogamulizumab, DA-EPOCH Protocol, CHOEP protocol
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy